MakeSense

Product NDC
69020-209
11-digit product format
690200209
Labeler code
69020
Product ID
69020-209_46674f2f-860b-44b2-8f74-75b9d9956d04
Type
HUMAN OTC DRUG
Nonproprietary name
Benzocaine Benzalkonium chloride
Dosage form
CREAM
Route
TOPICAL
Labeler
Cherry Hill Sales Co
Application
part348
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2014-07-31
Marketing end
0000-00-00
Substance
BENZOCAINE; BENZALKONIUM CHLORIDE
Active strength
5 g/100g; mg/100g
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct69020-209IInactivated by FDA2026-10-15
excluded packagepackage69020-20969020-209-21IInactivated by FDA2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage69020-209-21d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage69020-209-21f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage69020-209-212ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage69020-209-21a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage69020-209-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage69020-209-21cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage69020-209-21302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage69020-209-21ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage69020-209-210efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage69020-209-21ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage69020-209-21367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage69020-209-21557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproduct8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage69020-209-218af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproduct834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage69020-209-21834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproduct1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage69020-209-211332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage69020-209-21fb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproduct86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage69020-209-2186f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage69020-209-21bd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproduct8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage69020-209-218dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproducte2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage69020-209-21e2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproduct9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage69020-209-219bebd1f3094a…5416666fcb17…
2019-12-08 06:16 UTC · source 2019-12-05excluded productproduct110d247fa046…a55b01930146…
2019-12-08 06:16 UTC · source 2019-12-05excluded packagepackage69020-209-21110d247fa046…a55b01930146…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69020-209-212019-11-27C16284748780-19855e2a2-4abe-60a7-e053-dbdaa90a05bdDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69020-209-21MakeSenseFeminine Anti-itch21 g in 1 TUBECREAM211

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BENZALKONIUM CHLORIDEACTIVE INGREDIENTF5UM2KM3W7MAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
BENZOCAINEACTIVE INGREDIENTU3RSY48JW5MAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
BENZALKONIUMACTIVE MOIETY7N6JUD5X6YMAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
BENZOCAINEACTIVE MOIETYU3RSY48JW5MAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
CETOSTEARYL ALCOHOLINACTIVE INGREDIENT2DMT128M1SMAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
DIAZOLIDINYL UREAINACTIVE INGREDIENTH5RIZ3MPW4MAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1OMAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE4MAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
HYDROXYPROPYL BISSTEARYLDIMONIUM CHLORIDEINACTIVE INGREDIENTOVB1E9X12IMAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TMAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
PEG-100 STEARATEINACTIVE INGREDIENTYD01N1999RMAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
POLYETHYLENE GLYCOL 400INACTIVE INGREDIENTB697894SGQMAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHMAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1
WATERINACTIVE INGREDIENT059QF0KO0RMAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69020-209MAKESENSE FEMININE ANTI-ITCH (BENZOCAINE BENZALKONIUM CHLORIDE) CREAM [CHERRY HILL SALES CO]1Legacy NDC, 1 package rows20140812_7ab3eaaf-df96-4208-ab73-67d18fad35e6.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
997658benzocaine 5 % / benzalkonium chloride 0.13 % Vaginal CreamPSN7ab3eaaf-df96-4208-ab73-67d18fad35e61
997658benzalkonium chloride 1.3 MG/ML / benzocaine 50 MG/ML Vaginal CreamSCD7ab3eaaf-df96-4208-ab73-67d18fad35e61
997658benzalkonium chloride 0.13 % / benzocaine 5 % Vaginal CreamSY7ab3eaaf-df96-4208-ab73-67d18fad35e61

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
69020-209-216902002092121 g in 1 TUBE21 gHistorical